Global Ursodeoxycholic Acid Market Growth 2025-2031

Publication ID:

LPI04252857

Publication Date:

April 25, 2025

Pages:

105

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Ursodeoxycholic Acid market size is predicted to grow from US$ 592 million in 2025 to US$ 1055 million in 2031; it is expected to grow at a CAGR of 10.1% from 2025 to 2031.
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3伪, 7尾-2-hydroxy-5尾-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid API. In addition, the CAS number is 128-13-2.
The growing prevalence of liver diseases, such as primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and certain forms of liver cirrhosis, serves as a significant driver for the Ursodeoxycholic Acid (UDCA) market. As more individuals are diagnosed with these conditions due to improved medical awareness and diagnostic techniques, the demand for effective treatments like UDCA increases. UDCA has demonstrated efficacy in managing and alleviating symptoms of these liver diseases, positioning it as a valuable therapeutic option. The rising global burden of liver disorders, often associated with factors like aging and lifestyle changes, provides a sustained demand for UDCA as a key component in manufacturing medications to address these conditions.
One of the major challenges faced by the UDCA API market is the high cost of production, which can limit accessibility, especially in developing regions. The complex extraction and synthesis process of UDCA contributes to its expensive manufacturing, making it difficult for pharmaceutical companies to offer cost-effective treatments. Additionally, regulatory hurdles and stringent quality standards for drug approval add further pressure on manufacturers, which may slow down market growth.
APAC is the largest consumption place, with a consumption market share nearly 52% in 2023. Following APAC, Europe is the second largest consumption place with the consumption market share of 30%.
Global key Ursodeoxycholic Acid players cover ICE, Dipharma Francis, Daewoong Chemical, Zhongshan Bailing, PharmaZell GmbH, Suzhou Tianlv, Yun Gang Bio, Grindeks, etc. In terms of revenue, the global five largest companies occupied for a share nearly 72% in 2023.
The 鈥淯rsodeoxycholic Acid Industry Forecast鈥� looks at past sales and reviews total world Ursodeoxycholic Acid sales in 2024, providing a comprehensive analysis by region and market sector of projected Ursodeoxycholic Acid sales for 2025 through 2031. With Ursodeoxycholic Acid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ursodeoxycholic Acid industry.
This Insight Report provides a comprehensive analysis of the global Ursodeoxycholic Acid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ursodeoxycholic Acid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Ursodeoxycholic Acid market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ursodeoxycholic Acid and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ursodeoxycholic Acid.
This report presents a comprehensive overview, market shares, and growth opportunities of Ursodeoxycholic Acid market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Synthetic UDCA
Extraction UDCA
Segmentation by Application:
Pharmacy
Health Products
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ICE
Mitsubishi Tanabe Pharma
Daewoong Chemical
PharmaZell GmbH
Zhongshan Bailing
Dipharma Francis
Grindeks
Suzhou Tianlv
Yun Gang Bio
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ursodeoxycholic Acid market?
What factors are driving Ursodeoxycholic Acid market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ursodeoxycholic Acid market opportunities vary by end market size?
How does Ursodeoxycholic Acid break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ursodeoxycholic Acid Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Ursodeoxycholic Acid by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Ursodeoxycholic Acid by Country/Region, 2020, 2024 & 2031
2.2 Ursodeoxycholic Acid Segment by Type
2.2.1 Synthetic UDCA
2.2.2 Extraction UDCA
2.3 Ursodeoxycholic Acid Sales by Type
2.3.1 Global Ursodeoxycholic Acid Sales Market Share by Type (2020-2025)
2.3.2 Global Ursodeoxycholic Acid Revenue and Market Share by Type (2020-2025)
2.3.3 Global Ursodeoxycholic Acid Sale Price by Type (2020-2025)
2.4 Ursodeoxycholic Acid Segment by Application
2.4.1 Pharmacy
2.4.2 Health Products
2.5 Ursodeoxycholic Acid Sales by Application
2.5.1 Global Ursodeoxycholic Acid Sale Market Share by Application (2020-2025)
2.5.2 Global Ursodeoxycholic Acid Revenue and Market Share by Application (2020-2025)
2.5.3 Global Ursodeoxycholic Acid Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Ursodeoxycholic Acid Breakdown Data by Company
3.1.1 Global Ursodeoxycholic Acid Annual Sales by Company (2020-2025)
3.1.2 Global Ursodeoxycholic Acid Sales Market Share by Company (2020-2025)
3.2 Global Ursodeoxycholic Acid Annual Revenue by Company (2020-2025)
3.2.1 Global Ursodeoxycholic Acid Revenue by Company (2020-2025)
3.2.2 Global Ursodeoxycholic Acid Revenue Market Share by Company (2020-2025)
3.3 Global Ursodeoxycholic Acid Sale Price by Company
3.4 Key Manufacturers Ursodeoxycholic Acid Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ursodeoxycholic Acid Product Location Distribution
3.4.2 Players Ursodeoxycholic Acid Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Ursodeoxycholic Acid by Geographic Region
4.1 World Historic Ursodeoxycholic Acid Market Size by Geographic Region (2020-2025)
4.1.1 Global Ursodeoxycholic Acid Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Ursodeoxycholic Acid Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Ursodeoxycholic Acid Market Size by Country/Region (2020-2025)
4.2.1 Global Ursodeoxycholic Acid Annual Sales by Country/Region (2020-2025)
4.2.2 Global Ursodeoxycholic Acid Annual Revenue by Country/Region (2020-2025)
4.3 Americas Ursodeoxycholic Acid Sales Growth
4.4 APAC Ursodeoxycholic Acid Sales Growth
4.5 Europe Ursodeoxycholic Acid Sales Growth
4.6 Middle East & Africa Ursodeoxycholic Acid Sales Growth
5 Americas
5.1 Americas Ursodeoxycholic Acid Sales by Country
5.1.1 Americas Ursodeoxycholic Acid Sales by Country (2020-2025)
5.1.2 Americas Ursodeoxycholic Acid Revenue by Country (2020-2025)
5.2 Americas Ursodeoxycholic Acid Sales by Type (2020-2025)
5.3 Americas Ursodeoxycholic Acid Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ursodeoxycholic Acid Sales by Region
6.1.1 APAC Ursodeoxycholic Acid Sales by Region (2020-2025)
6.1.2 APAC Ursodeoxycholic Acid Revenue by Region (2020-2025)
6.2 APAC Ursodeoxycholic Acid Sales by Type (2020-2025)
6.3 APAC Ursodeoxycholic Acid Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ursodeoxycholic Acid by Country
7.1.1 Europe Ursodeoxycholic Acid Sales by Country (2020-2025)
7.1.2 Europe Ursodeoxycholic Acid Revenue by Country (2020-2025)
7.2 Europe Ursodeoxycholic Acid Sales by Type (2020-2025)
7.3 Europe Ursodeoxycholic Acid Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ursodeoxycholic Acid by Country
8.1.1 Middle East & Africa Ursodeoxycholic Acid Sales by Country (2020-2025)
8.1.2 Middle East & Africa Ursodeoxycholic Acid Revenue by Country (2020-2025)
8.2 Middle East & Africa Ursodeoxycholic Acid Sales by Type (2020-2025)
8.3 Middle East & Africa Ursodeoxycholic Acid Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ursodeoxycholic Acid
10.3 Manufacturing Process Analysis of Ursodeoxycholic Acid
10.4 Industry Chain Structure of Ursodeoxycholic Acid
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ursodeoxycholic Acid Distributors
11.3 Ursodeoxycholic Acid Customer
12 World Forecast Review for Ursodeoxycholic Acid by Geographic Region
12.1 Global Ursodeoxycholic Acid Market Size Forecast by Region
12.1.1 Global Ursodeoxycholic Acid Forecast by Region (2026-2031)
12.1.2 Global Ursodeoxycholic Acid Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Ursodeoxycholic Acid Forecast by Type (2026-2031)
12.7 Global Ursodeoxycholic Acid Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 ICE
13.1.1 ICE Company Information
13.1.2 ICE Ursodeoxycholic Acid Product Portfolios and Specifications
13.1.3 ICE Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 ICE Main Business Overview
13.1.5 ICE Latest Developments
13.2 Mitsubishi Tanabe Pharma
13.2.1 Mitsubishi Tanabe Pharma Company Information
13.2.2 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Product Portfolios and Specifications
13.2.3 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mitsubishi Tanabe Pharma Main Business Overview
13.2.5 Mitsubishi Tanabe Pharma Latest Developments
13.3 Daewoong Chemical
13.3.1 Daewoong Chemical Company Information
13.3.2 Daewoong Chemical Ursodeoxycholic Acid Product Portfolios and Specifications
13.3.3 Daewoong Chemical Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Daewoong Chemical Main Business Overview
13.3.5 Daewoong Chemical Latest Developments
13.4 PharmaZell GmbH
13.4.1 PharmaZell GmbH Company Information
13.4.2 PharmaZell GmbH Ursodeoxycholic Acid Product Portfolios and Specifications
13.4.3 PharmaZell GmbH Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 PharmaZell GmbH Main Business Overview
13.4.5 PharmaZell GmbH Latest Developments
13.5 Zhongshan Bailing
13.5.1 Zhongshan Bailing Company Information
13.5.2 Zhongshan Bailing Ursodeoxycholic Acid Product Portfolios and Specifications
13.5.3 Zhongshan Bailing Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Zhongshan Bailing Main Business Overview
13.5.5 Zhongshan Bailing Latest Developments
13.6 Dipharma Francis
13.6.1 Dipharma Francis Company Information
13.6.2 Dipharma Francis Ursodeoxycholic Acid Product Portfolios and Specifications
13.6.3 Dipharma Francis Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Dipharma Francis Main Business Overview
13.6.5 Dipharma Francis Latest Developments
13.7 Grindeks
13.7.1 Grindeks Company Information
13.7.2 Grindeks Ursodeoxycholic Acid Product Portfolios and Specifications
13.7.3 Grindeks Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Grindeks Main Business Overview
13.7.5 Grindeks Latest Developments
13.8 Suzhou Tianlv
13.8.1 Suzhou Tianlv Company Information
13.8.2 Suzhou Tianlv Ursodeoxycholic Acid Product Portfolios and Specifications
13.8.3 Suzhou Tianlv Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Suzhou Tianlv Main Business Overview
13.8.5 Suzhou Tianlv Latest Developments
13.9 Yun Gang Bio
13.9.1 Yun Gang Bio Company Information
13.9.2 Yun Gang Bio Ursodeoxycholic Acid Product Portfolios and Specifications
13.9.3 Yun Gang Bio Ursodeoxycholic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Yun Gang Bio Main Business Overview
13.9.5 Yun Gang Bio Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂